Skip to main content
Signal8

Wainman Paul R

SEC insider (Form 3/4/5 filer). CIK 0001603581. Director at IMMUCELL CORP /DE/ (ICCC). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 15, 2026. Located in PORTLAND, ME.

Companies Wainman Paul R has filed insider reports for

  • IMMUCELL CORP /DE/ (ICCC): Director
Wainman Paul R profile photo

Wainman Paul R

CIK: 0001603581

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMMUCELL CORP /DE/ logo
ICCC

IMMUCELL CORP /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Apr 15, 2026
    Award

    Non Qualified Stock Options (Right to buy)

    Direct
    11.9K shares-
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Apr 16, 2025
    Award

    Non Qualified Stock Options (Right to buy)

    Direct
    10K shares-
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Sep 20, 2024
    Award

    Non Qualified Stock Options (Right to buy)

    Direct
    10K shares at avg. $3.60-

1-3 of 3